Keating Investment Counselors’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $968K | Sell |
1,931
-37
| -2% | -$17.8K | 0.27% | 35 |
|
|
2026
Q1 | $967K | Sell |
1,968
-825
| -30% | -$448K | 0.24% | 35 |
|
|
2025
Q4 | $1.62M | Sell |
2,793
-83
| -3% | -$46.9K | 0.45% | 32 |
|
|
2025
Q3 | $1.39M | Sell |
2,876
-100
| -3% | -$46.5K | 0.4% | 34 |
|
|
2025
Q2 | $1.21M | Sell |
2,976
-55
| -2% | -$23K | 0.36% | 34 |
|
|
2025
Q1 | $1.51M | Sell |
3,031
-744
| -20% | -$403K | 0.45% | 32 |
|
|
2024
Q4 | $1.96M | Sell |
3,775
-10
| -0.3% | -$5.5K | 0.61% | 30 |
|
|
2024
Q3 | $2.34M | Sell |
3,785
-75
| -2% | -$44.4K | 0.7% | 29 |
|
|
2024
Q2 | $2.13M | Sell |
3,860
-735
| -16% | -$421K | 0.69% | 28 |
|
|
2024
Q1 | $2.67M | Sell |
4,595
-1,813
| -28% | -$1.02M | 0.86% | 27 |
|
|
2023
Q4 | $3.4M | Sell |
6,408
-50
| -0.8% | -$24.2K | 1.22% | 27 |
|
|
2023
Q3 | $3.27M | Buy |
6,458
+312
| +5% | +$166K | 1.11% | 27 |
|
|
2023
Q2 | $3.21M | Sell |
6,146
-425
| -6% | -$229K | 1.16% | 27 |
|
|
2023
Q1 | $3.79M | Sell |
6,571
-270
| -4% | -$152K | 1.43% | 25 |
|
|
2022
Q4 | $3.77M | Buy |
6,841
+806
| +13% | +$427K | 1.47% | 26 |
|
|
2022
Q3 | $3.06M | Sell |
6,035
-65
| -1% | -$36.4K | 1.37% | 26 |
|
|
2022
Q2 | $3.31M | Sell |
6,100
-730
| -11% | -$402K | 1.4% | 25 |
|
|
2022
Q1 | $4.03M | Sell |
6,830
-175
| -2% | -$101K | 1.73% | 22 |
|
|
2021
Q4 | $4.67M | Hold |
7,005
| – | – | 2.07% | 20 |
|
|
2021
Q3 | $4M | Hold |
7,005
| – | – | 1.87% | 22 |
|
|
2021
Q2 | $3.53M | Sell |
7,005
-585
| -8% | -$276K | 1.62% | 24 |
|
|
2021
Q1 | $3.46M | Sell |
7,590
-1,398
| -16% | -$667K | 1.66% | 25 |
|
|
2020
Q4 | $4.19M | Sell |
8,988
-815
| -8% | -$382K | 2.09% | 20 |
|
|
2020
Q3 | $4.33M | Sell |
9,803
-685
| -7% | -$283K | 2.27% | 17 |
|
|
2020
Q2 | $3.8M | Sell |
10,488
-355
| -3% | -$119K | 2.09% | 18 |
|
|
2020
Q1 | $3.08M | Sell |
10,843
-1,285
| -11% | -$405K | 1.88% | 22 |
|
|
2019
Q4 | $3.94M | Sell |
12,128
-160
| -1% | -$48.5K | 1.72% | 24 |
|
|
2019
Q3 | $3.58M | Sell |
12,288
-3,662
| -23% | -$1.05M | 1.61% | 27 |
|
|
2019
Q2 | $4.68M | Sell |
15,950
-665
| -4% | -$183K | 2.09% | 23 |
|
|
2019
Q1 | $4.55M | Sell |
16,615
-795
| -5% | -$198K | 2.06% | 23 |
|
|
2018
Q4 | $3.9M | Sell |
17,410
-1,975
| -10% | -$463K | 1.97% | 21 |
|
|
2018
Q3 | $4.73M | Sell |
19,385
-1,310
| -6% | -$301K | 2.04% | 19 |
|
|
2018
Q2 | $4.29M | Sell |
20,695
-1,020
| -5% | -$217K | 2.03% | 22 |
|
|
2018
Q1 | $4.48M | Sell |
21,715
-5,635
| -21% | -$1.18M | 2.07% | 20 |
|
|
2017
Q4 | $5.19M | Sell |
27,350
-750
| -3% | -$144K | 2.21% | 20 |
|
|
2017
Q3 | $5.32M | Sell |
28,100
-460
| -2% | -$83.3K | 2.31% | 21 |
|
|
2017
Q2 | $4.98M | Sell |
28,560
-12,548
| -31% | -$2.11M | 2.18% | 23 |
|
|
2017
Q1 | $6.31M | Sell |
41,108
-465
| -1% | -$71.1K | 2.81% | 15 |
|
|
2016
Q4 | $5.87M | Buy |
41,573
+175
| +0.4% | +$25.8K | 2.77% | 15 |
|
|
2016
Q3 | $6.58M | Sell |
41,398
-675
| -2% | -$104K | 3.21% | 10 |
|
|
2016
Q2 | $6.22M | Buy |
42,073
+4,045
| +11% | +$597K | 3.05% | 13 |
|
|
2016
Q1 | $5.38M | Sell |
38,028
-1,885
| -5% | -$253K | 2.63% | 17 |
|
|
2015
Q4 | $5.66M | Sell |
39,913
-50
| -0.1% | -$6.67K | 2.84% | 15 |
|
|
2015
Q3 | $4.89M | Hold |
39,963
| – | – | 2.63% | 17 |
|
|
2015
Q2 | $5.19M | Sell |
39,963
-725
| -2% | -$94.5K | 2.64% | 16 |
|
|
2015
Q1 | $5.47M | Hold |
40,688
| – | – | 2.73% | 15 |
|
|
2014
Q4 | $5.1M | Sell |
40,688
-55
| -0.1% | -$6.69K | 2.54% | 16 |
|
|
2014
Q3 | $4.96M | Sell |
40,743
-3,250
| -7% | -$395K | 2.56% | 19 |
|
|
2014
Q2 | $5.19M | Sell |
43,993
-410
| -0.9% | -$48.3K | 2.5% | 20 |
|
|
2014
Q1 | $5.34M | Sell |
44,403
-7,280
| -14% | -$866K | 2.66% | 16 |
|
|
2013
Q4 | $5.75M | Hold |
51,683
| – | – | 2.94% | 16 |
|
|
2013
Q3 | $4.76M | Sell |
51,683
-170
| -0.3% | -$15.4K | 2.66% | 21 |
|
|
2013
Q2 | $4.39M | Buy |
+51,853
| New | +$4.32M | 2.47% | 22 |
|
Other funds holding TMO
RG
LT
ATO
QP
CF
Keating Investment Counselors's TMO Position: Q2 2026 in Review
Keating Investment Counselors reduced its Thermo Fisher Scientific (TMO) stake by 1.9% in Q2 2026, selling an estimated $17.8K and leaving 1,931 shares worth $968K. The position accounts for 0.27% of the portfolio, ranked #35.
Keating Investment Counselors first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $6.58M in Q3 2016. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Keating Investment Counselors held 1,931 shares of Thermo Fisher Scientific worth $968K as of Q2 2026.
- Keating Investment Counselors sold 37 Thermo Fisher Scientific shares in Q2 2026, an estimated $17.8K.
- Thermo Fisher Scientific made up 0.27% of Keating Investment Counselors's portfolio in Q2 2026, its #35 holding.
- Keating Investment Counselors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Keating Investment Counselors's Thermo Fisher Scientific position peaked at $6.58M in Q3 2016.
- 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Keating Investment Counselors's 13F filing for Q2 2026, filed 16 Jul 2026.